Table 2 Medical Indications for transfusion among study participants at UTH in Lusaka, Zambia (N = 1086)*
Maternal HIV status | P Value | ||
|---|---|---|---|
HIV + (n = 265) | HIV- (n = 821) | ||
Medical indications for blood or component transfusion± | |||
Pregnancy-related causes | 164 | 489 | 0.52 |
Placenta abruption | 8 (4.9) | 38 (7.8) | 0.30 |
Postpartum hemorrhage (PPH) | 26 (15.9) | 119 (24.3) | 0.06 |
Disseminated Intravascular Coagulation (DIC) and HELLP syndrome* | 1 (0.6) | 11 (2.2) | 0.31 |
Uterine rupture | 3 (1.8) | 9 (1.8) | 1 |
Gestational thrombocytopenia | 0 (0) | 0 (0) | ⁻ |
Complications of ectopic pregnancy | 23 (14) | 44 (9) | 0.06 |
Acute anemia (non-related to PPH) | 11 (6.7) | 13 (2.7) | 0.03 |
Other | 92 (56.1) | 255 (52.1) | 0.29 |
Non-pregnancy related causes | 7 | 17 | 0.63 |
Motor-vehicle accident | 1 (14.3) | 7 (41.2) | 0.69 |
Massive trauma | 0 (0) | 1 (5.9) | 1 |
Idiopathic thrombocytopenic purpura | 0 (0) | 0 (0) | ⁻ |
Complications of malaria | 0 (0) | 1 (5.9) | 1 |
Sickle cell anemia (SCA) | 0 (0) | 0 (0) | ⁻ |
Chronic anemia/Anemia of chronic disease (excluding SCA) | 1 (0.4) | 0 (0) | 0.24 |
Other | 5 (71.4) | 8 (47.1) | 0.33 |
